US Edition
Teva Pharmaceutical Industries Limited (NYSE:TEVA) Receives Average Recommendation of “Buy” from Analysts
Summary by reporter.am
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Teva Pharmaceutical Industries Limited (NYSE:TEVA) Receives Average Recommendation of “Buy” from Analysts
Teva Pharmaceutical Industries Limited (NYSE:TEVA – Get Free Report) has been given an average recommendation of “Buy” by the eight research firms that are presently covering the stock, MarketBeat Ratings reports. Seven analysts have rated the stock with a buy rating and one has issued a strong buy rating on the company. The average 1-year […]
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
